Lanadelumab Launch Insight 2019

The press release focused on the Drug launch report providing detailed drug description, its chemical composition, mechanism of action, route of administration, competitor drugs in the market and upcoming ones and the market size.

Press Release

Lanadelumab Launch Insight 2019” report by DelveInsight provides comprehensive insights about Lanadelumab ‘s launch. The report covers all indications for which Lanadelumab is being developed and also provides its competitive landscape for the major indications. The report further includes patent details, forecasted sales till 2022 and post-launch market positioning.

Lanadelumab Post-Launch Market Positioning Scenario

The report will provide a clear picture of market positioning of the upcoming launch of Lanadelumab and will also provide insight about how Lanadelumab will evolve in the market as well as within its respective class. The report provides detailed information of clinical trials that have been or are being conducted for this product. Analysis and Insightful information around the clinical trials are provided by assessment of the trial results.

Lanadelumab Attributes Analysis

Attributes analysis carried out by our analysts helps in understanding how the upcoming launch scores itself in comparison to other competitors (both marketed and pipeline). The scoring and analysis have been based upon scrutinizing data from all key clinical trials for the product. Ahead to head comparison with marketed products if available is scanned thoroughly. Further, analyzing data of other competitors with regards to the product also assists in proper scoring of the product in its space.

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
• Detailed product description including its chemical properties, molecule type and mechanism of action
• A detailed description of non-clinical and clinical studies using Lanadelumab for all the indications
• Patent expiry analysis of the drug along with other competitors in the market
Lanadelumab Forecasted sales till 2022
Lanadelumab market positioning analysis
• Lanadelumab class share evolution

Request for sample pages

Reasons to Buy
• Establish a comprehensive understanding of the emerging product, Lanadelumab
• Understand Lanadelumab `s therapeutic performance through pre-clinical and clinical characterization in its associated indications
• Identify the upcoming launch timeline of Lanadelumab
• Plan an effective competitive strategy by understanding Lanadelumab `s market positioning post-launch and its in-class market evolution
• Plan counter-effective strategies around Lanadelumab `s patents expiry details
• Understand and analyze post-launch growth prospects of Lanadelumab through its forecasted sales
• Identify Lanadelumab’s attributes and use it for target finding, drug repurposing, and precision medicine
• Identify the competitors in the same space as Lanadelumab

Table of contents

1. Report Introduction
2. Lanadelumab Overview
3. Lanadelumab: Mechanism of action
4. Pre-clinical Characterization
• Indication 1
• Indication 2
5. Clinical Characterization
• Indication 1
• Indication 2
6. Product Developmental Activities
• Collaboration
• Mergers & Acquisitions
• Financing
7. Lanadelumab Market Evolution
8. Lanadelumab Class Share Evolution
9. Lanadelumab Market Positioning
10. Patent Expiry Analysis
11. Competitive Landscape for Lanadelumab in major indications
Consulting Services
About DelveInsight


Related Articles